Amryt Pharma, Joe Wiley CEO
Dec 12, 2016, 09:16 AM
Share Talk speak to #AMYT CEO Joe Wiley about their recent 'Transformational Licence Agreement' RNS of 5 Dec 2016. We also get some more background information about Amryt Pharma and their focus on best-in-class treatments for rare and orphan diseases.